A cost analysis of coronary stenting without anticoagulation versus stenting with anticoagulation using warfarin.
A case-controlled study was performed comparing hospitalization costs and length of hospital stay in a group of patients managed with antiplatelet therapy only, versus a group treated with anticoagulation using warfarin after coronary artery stenting. The patients managed with antiplatelet therapy alone had significantly reduced total hospitalization costs and a significantly reduced average hospital stay than patients managed with anticoagulation.
Goods
C M
CM
Division of Cardiovascular Diseases, University of Alabama of Birmingham 35294, USA.
Liu
M W
MW
Iyer
S S
SS
Yadav
J S
JS
al-Shaibi
K F
KF
Dean
L S
LS
Roubin
G S
GS
D000368:Aged; D000407:Alabama; D015906:Angioplasty, Balloon, Coronary / Q000191:economics*; D016022:Case-Control Studies; D003365:Costs and Cost Analysis; D005260:Female; D017721:Hospital Costs / Q000706:statistics & numerical data*; D006801:Humans; D007902:Length of Stay / Q000191:economics; D008297:Male; D008875:Middle Aged; D015607:Stents / Q000191:economics*; D014859:Warfarin / Q000191:economics* / Q000627:therapeutic use
D014859:Warfarin